New Delhi: Health and Family Welfare Ministry has issued new clinical guidance for the management of adult Covid-19 patients in the country. Under the new guidance, active tuberculosis has been added to the high-risk disease for Covid-19. People above the age of 60, people having cardiovascular disease, hypertension, diabetes, HIV, chronic lung, kidney, liver disease, cerebrovascular disease, and obesity are in the high-risk category.

The new clinical guidance states that anti-inflammatory or immunomodulatory therapy such as steroids can have a risk of secondary infection such as invasive mucormycosis when used too early, at a higher dose, or for longer than required.

Health and Family Welfare Ministry has advised that remdesivir not be used in patients who are not on oxygen support or in-home settings. It said, remdesivir may be considered only in patients having moderate to severe disease of Covid-19 requiring supplemental oxygen. The guidance further states that Tocilizumab may be considered when rapidly progressing Covid-19 requires oxygen supplementation.

No Comments For This Post, Be first to write a Comment.
Leave a Comment
Enter the code shown:

Can't read the image? click here to refresh

Todays Epaper

neerus indian ethnic wear
Latest Urdu News

Which cricket team will win the IPL 2022?

Gujarat Titans
Lucknow Super Giants
Rajasthan Royals